Techniques for Glyconanoparticle Development
Glyconanoparticle: The Rising Star in Biomedicine
As an emerging nanomaterial, glyconanoparticle provides new ideas and methods for solving many disease problems. Sugar chains, as important recognition molecules on the cell surface, give glyconanoparticle specific biological functions, giving it unique advantages in targeted drug delivery, bioimaging, tissue engineering, etc. By loading drugs or probe molecules onto the surface of glyconanoparticle, accurate disease diagnosis and treatment are achieved, the treatment effect is improved, and side effects are reduced. In addition, glyconanoparticle is also used to construct biomaterials with good biocompatibility to promote tissue regeneration and repair. CD BioGlyco has developed an advanced GlycoNano™ Platform, which aims to develop new glyconanomaterial by integrating multidisciplinary knowledge such as sugar chemistry, nanotechnology, and biomedicine. The glyconanoparticle is applied to the biomedical field to solve major challenges facing current medical care, such as cancer and neurodegenerative diseases.
Building Tomorrow's Medicine: Innovative Techniques in Glyconanoparticle Development
With our deep experience in sugar chemistry and nanotechnology, we have established a complete Glyconanoparticle Preparation System. By fine-tuning the synthesis parameters, we customize glyconanoparticles that meet your requirements in terms of particle size, morphology, surface functionalization, etc. Our technologies for glyconanoparticle development include but are not limited to:
Hydrophobic Effect
We provide a simple and efficient glyconanoparticle preparation method. Through self-assembly based on the hydrophobic effect, we construct glyconanoparticles with good stability and biocompatibility to meet your various needs in the fields of biomedicine, materials science, etc.
CuAAC
Using the CuAAC reaction, sugar molecules and nanoparticles are efficiently connected to construct glyconanoparticles with customized functions to meet your various needs in the fields of biomedicine, materials science, etc. This method has mild reaction conditions, high yield, and few side reactions.
Amide Coupling
Sugar chains are connected to nanomaterials through peptide bonds. This natural amide bond not only gives glyconanoparticle excellent biocompatibility, but also achieves precise control of sugar chain density and orientation by precisely regulating the amino acid sequence, providing unlimited possibilities for biomedical research.
Nucleophilic Substitution
The abundant hydroxyl groups on sugar molecules are used as nucleophiles to undergo nucleophilic substitution reactions with leaving groups on the surface of nanoparticles. This reaction condition is mild and highly selective, achieving precise modification of sugar chains on the surface of nanoparticles.
Photocoupling
We prepare glyconanoparticles with diverse structures and rich functions by selecting different photosensitive groups and reaction systems. Whether it is for drug delivery, bioimaging or tissue engineering, we tailor the most suitable glyconanoparticles for you.
With advanced technology, we provide clients with unparalleled glyconanoparticle production services. Our service process is as follows:
Sugar Chain Design and Synthesis
We customize the synthesis of sugar chains with various complex structures for you, including natural oligosaccharides, glycoconjugates, and artificial sugar chains with special functions. We use strategies such as chemical synthesis, enzymatic synthesis, and combinatorial synthesis to meet the needs of different clients. Through strict quality control, the purity and structural accuracy of the synthesized products are ensured.
Nanocarrier Construction
We provide flexible nanocarrier options. Through chemical bonding, physical adsorption, self-assembly, and other modification methods, various types of sugar chains are accurately modified to the surface of nanocarriers, achieving precise regulation of the surface properties of nanomaterials to meet your application needs in different fields.
Glyconanoparticle Characterization
To ensure the quality and performance of glyconanoparticles, high-resolution technologies such as nuclear magnetic resonance (NMR) and mass spectrometry (MS) are used to accurately characterize the structure and purity of sugar chains. At the same time, we also use imaging technologies such as transmission electron microscopy to visually observe the morphology and size distribution of glyconanoparticles. The combination of these advanced technologies enables a full range of characterization of glyconanoparticles.
Glyconanoparticle Functionalization
Glyconanoparticles are given more diverse biological functions by introducing functional molecules such as fluorescent molecules and drug molecules. For example, fluorescent molecules are introduced to achieve fluorescent imaging of cells, which is used to study cell uptake, localization, and metabolic processes. Drug molecules are introduced to construct targeted drug delivery systems, thereby achieving precise treatment of diseases such as tumors.
Workflow

Applications
- Materials science: Introducing glyconanoparticles into material systems improves the biocompatibility, biodegradability, and surface properties of materials. For example, glyconanoparticles are used to prepare biomedical materials, smart response materials, and functional coatings.
- Cosmetic field: Glyconanoparticles are used as carriers of cosmetics to deliver active ingredients to the deep layers of the skin, improving the efficacy of skin care products. In addition, glyconanoparticles also improve the texture and feel of cosmetics.
- Biomedicine: Glyconanoparticles have broad application prospects in drug delivery, vaccine development, tissue engineering, biosensors, and other fields. By functionalizing the surface of sugar particles, targeted drug delivery, improved vaccine immunogenicity, promoted tissue regeneration, and constructed highly sensitive biosensors are achieved.
Advantages
- Our team brings together first-class experts in sugar chemistry and nanotechnology and has a world-leading R&D platform. We not only master the core technologies such as sugar chain synthesis and nanoparticle preparation but also cleverly combine these technologies to tailor a variety of functionalized glyconanoparticles for you.
- Our services cover the entire process from concept design to product delivery, including sugar chain design and synthesis, nanocarrier construction, glyconanoparticle characterization, and glyconanoparticle functionalization.
- We integrate knowledge from multiple disciplines such as chemistry, biology, and materials science to provide innovative solutions for your research. Whether it is for drug delivery, gene therapy, bioimaging, or tissue engineering, we meet your specific needs.
Publication Data
DOI: 10.3390/nano11051162
Journal: Nanomaterials
Published: 2021
IF: 4.4
Results: The authors used nanoprecipitation to self-assemble two amphiphilic glycopolymers in different ratios to obtain polystyrene-block-maltoheptaose copolymer (PS-b-MH) and polystyrene-block-β-cyclodextrin copolymer (PS-b-βCD). Their spherical morphology and nanosize were characterized by dynamic light scattering, scanning, and transmission electron microscopy. In addition, the obtained glyconanoparticles exhibited classical electroactivity by post-functionalization with water-soluble redox compounds using the CD inclusion property. In summary, the regulation of the β-CD surface density on the glyconanoparticle shell provides an attractive method for the preparation of glyconanoparticles with different electroactive properties.
Fig.1 Strategy for functionalized glyconanoparticles of multifunctional redox platform. (Carrière, et al., 2021)
Frequently Asked Questions
- What are the advantages of glyconanoparticles?
Glyconanoparticle has excellent biocompatibility, specific targeting ability, and multifunctionality, showing great potential in the biomedical field. Sugar chains, as its biological recognition unit, give nanoparticles a high affinity with biological systems. At the same time, by introducing different functional molecules, it achieves precise drug delivery, efficient biological imaging, and other functions. -
How to customize glyconanoparticles?
Contact us to provide detailed information on sugar chain structure, nanoparticle type, and functionalization requirements. Our team will tailor glyconanoparticles to your needs. Whether it is the type, length, connection method of sugar chains, or the material and size of nanoparticles, we precisely control them. Our powerful technology platform and professional team provide you with comprehensive technical support.
CD BioGlyco has many years of experience in glycobiology and nanomaterials research and development, providing you with high-quality and efficient glyconanoparticle development services. If you need glyconanoparticles, please feel free to contact us and we will tailor the best solution for you.
Reference
- Carrière, M.; et al. Functionalizable glyconanoparticles for a versatile redox platform. Nanomaterials. 2021, 11(5): 1162.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





